251 related articles for article (PubMed ID: 34562537)
1. Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence.
Paskeh MDA; Mirzaei S; Orouei S; Zabolian A; Saleki H; Azami N; Hushmandi K; Baradaran B; Hashmi M; Aref AR; Ertas YN; Zarrabi A; Ashrafizadeh M; Samarghandian S
Int J Biol Macromol; 2021 Nov; 191():727-737. PubMed ID: 34562537
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
Entezari M; Taheriazam A; Orouei S; Fallah S; Sanaei A; Hejazi ES; Kakavand A; Rezaei S; Heidari H; Behroozaghdam M; Daneshi S; Salimimoghadam S; Mirzaei S; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Oct; 154():113609. PubMed ID: 36037786
[TBL] [Abstract][Full Text] [Related]
3. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.
Chakrabortty A; Patton DJ; Smith BF; Agarwal P
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510280
[TBL] [Abstract][Full Text] [Related]
4. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.
Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A
Microrna; 2020; 9(3):198-215. PubMed ID: 31686643
[TBL] [Abstract][Full Text] [Related]
5. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
Shin VY; Chu KM
World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
7. Interplay between SOX9 transcription factor and microRNAs in cancer.
Ashrafizadeh M; Zarrabi A; Orouei S; Zabolian A; Saleki H; Azami N; Bejandi AK; Mirzaei S; Janaghard MN; Hushmandi K; Nabavi N; Baradaran B; Kumar AP; Makvandi P; Samarghandian S; Khan H; Hamblin MR
Int J Biol Macromol; 2021 Jul; 183():681-694. PubMed ID: 33957202
[TBL] [Abstract][Full Text] [Related]
8. The role of miRNA-223 in cancer: Function, diagnosis and therapy.
Gao Y; Lin L; Li T; Yang J; Wei Y
Gene; 2017 Jun; 616():1-7. PubMed ID: 28322994
[TBL] [Abstract][Full Text] [Related]
9. Role of phytochemicals in the modulation of miRNA expression in cancer.
Debnath T; Deb Nath NC; Kim EK; Lee KG
Food Funct; 2017 Oct; 8(10):3432-3442. PubMed ID: 28782785
[TBL] [Abstract][Full Text] [Related]
10. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
11. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
Shekhar R; Kumari S; Vergish S; Tripathi P
Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the tumour-regulatory roles of miR-1275 in cancer.
Chong ZX; Yeap SK; Ho WY; Fang CM
Pathol Res Pract; 2022 Feb; 230():153745. PubMed ID: 34953353
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-375: potential cancer suppressor and therapeutic drug.
Wei J; Lu Y; Wang R; Xu X; Liu Q; He S; Pan H; Liu X; Yuan B; Ding Y; Zhang J
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34494089
[TBL] [Abstract][Full Text] [Related]
15. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
[TBL] [Abstract][Full Text] [Related]
16. A minor review of microRNA-338 exploring the insights of its function in tumorigenesis.
Yi Q; Cui H; Liao Y; Xiong J; Ye X; Sun W
Biomed Pharmacother; 2021 Jul; 139():111720. PubMed ID: 34243620
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-217: A regulator of human cancer.
Zhou S; Zhu C; Pang Q; Liu HC
Biomed Pharmacother; 2021 Jan; 133():110943. PubMed ID: 33254014
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Progressive Mechanisms Mediating miRNA-Protein Interaction.
Konishi H; Sato H; Takahashi K; Fujiya M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830186
[TBL] [Abstract][Full Text] [Related]
19. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators.
Mirzaei S; Zarrabi A; Asnaf SE; Hashemi F; Zabolian A; Hushmandi K; Raei M; Goharrizi MASB; Makvandi P; Samarghandian S; Najafi M; Ashrafizadeh M; Aref AR; Hamblin MR
Life Sci; 2021 Mar; 268():119005. PubMed ID: 33421526
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases.
Li S; Liang Z; Xu L; Zou F
Mol Cell Biochem; 2012 Jan; 360(1-2):147-58. PubMed ID: 21909994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
